The Senate passed a bill Saturday afternoon that would limit copayments for insulin at $35 for a month’s supply and add coverage for insulin devices into state code for the first time.
House Bill 4252 bill would cap a month’s supply of insulin at $35, down from the current $100 limit. The cost sharing for devices — including blood glucose test strips, glucometers, lancets, lancing devices and insulin syringes — would be capped at $100.
Insulin pumps, small devices that regulate blood sugar and automatically inject insulin through a small tube beneath the skin, would be capped at a cost of $250.
The bill will need to go back to the House of Delegates for final approval.
The Senate is in recess until 5 p.m.
